Mineralys Therapeutics Advances Drug Commercialization Through Comprehensive Contract Support

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company, engaged Faegre Drinker to provide comprehensive support in reviewing, revising, negotiating, and finalizing a broad range of commercial contracts as the company advances its drug approval and commercialization efforts. Over the past several years, our team has assisted Mineralys with more than 100 contracts, spanning from straightforward nondisclosure agreements requiring minimal negotiation to complex, long-term supply agreements that are critical to their business objectives. In addition to our core contract work, we coordinated with the firm's technology transactions and health care regulatory teams to facilitate legal counsel across specialized areas.